LEADER 03748nam  2200853z- 450 
001 9910557780303321
005 20231214133637.0
035   $a(CKB)5400000000045586
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76729
035   $a(EXLCZ)995400000000045586
100   $a20202201d2021      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aIonic Liquids and Deep Eutectic Solvents for Application in Pharmaceutics
210   $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021
215   $a1 electronic resource (154 p.)
311   $a3-0365-0056-1 
311   $a3-0365-0057-X 
330   $aDear Colleagues,   In recent years, functional coating technology has attracted increased attention due to its effective potential for improved engineered materials. Growing demand for new materials with synergistic properties pushed research toward a new field to obtain innovative and smart coatings with functional capabilities that greatly differ from the conventional ones. In such a context, the expression of ?functional coatings? has acquired specific relevance. This Special Issue will assess cutting-edge developments in this research area for the improvement and growth of actual performance, industrial scale-up, and marketability of functional coatings. This Special Issue is useful for researchers who are approaching this application context to improve their knowledge, with the aim of providing valuable scientific support for new research paths concerning functional surface engineering design and tailoring.   Prof. Luigi Calabrese, Prof. Edoardo Proverbio Guest Editors
606   $aTechnology: general issues$2bicssc
610   $aionic liquids
610   $atransdermal
610   $asynergy
610   $apermeation enhancer
610   $achemical
610   $aphysical
610   $aTransdermal drug delivery systems
610   $aionic liquid
610   $alipophilic salt
610   $adrug delivery
610   $adrug absorption
610   $apoorly water-soluble drug
610   $alumefantrine
610   $alipid-based formulation
610   $aSEDDS
610   $alipid formulation classification system
610   $aactive pharmaceutical ingredients-ionic liquids and organic salts (API-OSILs)
610   $apenicillin G and amoxicillin hydrolysate derivatives
610   $asensitive bacteria
610   $aresistant bacteria
610   $aalendronic acid
610   $aActive Pharmaceutical Ingredients
610   $aAPI-OSILs
610   $aanticancer drugs
610   $adeep eutectic mixtures
610   $aketoprofen
610   $anon-steroidal anti-inflammatory drugs (NSAIDs)
610   $alocal anesthetics
610   $aprocaine
610   $abenzocaine
610   $atetracaine
610   $aanticrystal engineering
610   $amechanochemistry
610   $abiocompatible
610   $atransdermal drug delivery system
610   $amicroemulsion
610   $aactive pharmaceutical ingredients as organic salts and ionic liquids (API-OSILs)
610   $aantibiotics
610   $aciprofloxacin
610   $afluoroquinolones
610   $anorfloxacin
610   $apolymorphism
615  7$aTechnology: general issues
700   $aBranco$b Luis Cobra$4edt$01278699
702   $aSantos$b Miguel$4edt
702   $aBranco$b Luis Cobra$4oth
702   $aSantos$b Miguel$4oth
906   $aBOOK
912   $a9910557780303321
996   $aIonic Liquids and Deep Eutectic Solvents for Application in Pharmaceutics$93013749
997   $aUNINA